Cargando…

Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer

INTRODUCTION: We evaluated whether CK19, one of the main cytoskeleton proteins of epithelial cells, is released as full-length protein from viable tumor cells and whether this property is relevant for metastatic progression in breast cancer patients. METHODS: EPISPOT (EPithelial ImmunoSPOT) assays w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alix-Panabières, Catherine, Vendrell, Jean-Pierre, Slijper, Monique, Pellé, Olivier, Barbotte, Eric, Mercier, Grégoire, Jacot, William, Fabbro, Michel, Pantel, Klaus
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2716508/ https://www.ncbi.nlm.nih.gov/pubmed/19549321 http://dx.doi.org/10.1186/bcr2326

Ejemplares similares

Crucial roles of circulating tumor cells in the metastatic cascade and tumor immune escape: biology and clinical translation
por: Pantel, Klaus, et al.
Publicado: (2022)

Cell lines from circulating tumor cells
por: Pantel, Klaus, et al.
Publicado: (2015)

Liquid biopsy: from discovery to clinical implementation
por: Alix‐Panabières, Catherine, et al.
Publicado: (2021)

Functional analysis of circulating tumour cells: the KEY to understand the biology of the metastatic cascade
por: Eslami-S, Zahra, et al.
Publicado: (2022)

Clinical relevance and biology of circulating tumor cells
por: Bednarz-Knoll, Natalia, et al.
Publicado: (2011)

Micrometastatic spread in breast cancer: detection, molecular characterization and clinical relevance
por: Fehm, Tanja, et al.
Publicado: (2008)

Mechanobiology and survival strategies of circulating tumor cells: a process towards the invasive and metastatic phenotype
por: Kurma, Keerthi, et al.
Publicado: (2023)

The Metastatic Cascade as the Basis for Liquid Biopsy Development
por: Eslami-S, Zahra, et al.
Publicado: (2020)

Cytokeratin 7-positive/cytokeratin 20-negative cecal adenocarcinoma metastatic to the uterine cervix: a case report
por: Toyoshima, Masafumi, et al.
Publicado: (2016)

Cytokeratin-Positive Osteosarcoma Simulating Sarcomatoid Metastatic Carcinoma
por: Murtaza, Hamza, et al.
Publicado: (2020)

High Sensitivity of Circulating Tumor Cells Derived from a Colorectal Cancer Patient for Dual Inhibition with AKT and mTOR Inhibitors
por: Smit, Daniel J., et al.
Publicado: (2020)

Analysis of Circulating Tumor Cells in Patients with Non-Metastatic High-Risk Prostate Cancer before and after Radiotherapy Using Three Different Enumeration Assays
por: Budna-Tukan, Joanna, et al.
Publicado: (2019)

Combined immunohistochemistry of β-catenin, cytokeratin 7, and cytokeratin 20 is useful in discriminating primary lung adenocarcinomas from metastatic colorectal cancer
por: Ikeda, Satoshi, et al.
Publicado: (2006)

EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer
por: Serrano, Maria J., et al.
Publicado: (2014)

Improved detection of circulating tumor cells in non-metastatic high-risk prostate cancer patients
por: Kuske, Andra, et al.
Publicado: (2016)

Metastatic Seminoma with Positive Staining of Cytokeratin and MOC31: A Diagnostic Pitfall
por: Fan, Jiaming, et al.
Publicado: (2021)

Serum Cytokeratin 18 as a Metastatic and Therapeutic Marker for Extramammary Paget’s Disease
por: URANO-TAKAOKA, Mariko, et al.
Publicado: (2022)

Autologous cell lines from circulating colon cancer cells captured from sequential liquid biopsies as model to study therapy-driven tumor changes
por: Soler, Alexandra, et al.
Publicado: (2018)

Stem Cell Markers (Cytokeratin 17 and Cytokeratin 19) in Scarring and Nonscarring Alopecia
por: El Sakka, Dalia, et al.
Publicado: (2016)

“Circulating Tumor Cells: Finding Rare Events for a Huge Knowledge of Cancer Dissemination”
por: Alix-Panabières, Catherine
Publicado: (2020)

Clinical significance of cytokeratin 19 and OCT4 as survival markers in non-metastatic and metastatic breast cancer patients
por: Abdelaziz, Lobna A., et al.
Publicado: (2022)

Cytokeratin phosphorylation, cytokeratin filament severing and the solubilization of the maternal mRNA Vg1
Publicado: (1991)

Identification of relevant prognostic values of cytokeratin 20 and cytokeratin 7 expressions in lung cancer
por: Luo, Hai-Tao, et al.
Publicado: (2017)

Evaluation of Cytokeratin-7 and Cytokeratin-19 Expression Relationship with Gleason Score in Prostatic Adenocarcinoma
por: Soltanipur, Masood, et al.
Publicado: (2023)

Is There One Key Step in the Metastatic Cascade?
por: Dujon, Antoine M., et al.
Publicado: (2021)

Cytokeratins in gastroenterology. Systematic review
por: Pastuszak, Marek, et al.
Publicado: (2015)

Detection of Androgen Receptor Variant 7 (ARV7) mRNA Levels in EpCAM-Enriched CTC Fractions for Monitoring Response to Androgen Targeting Therapies in Prostate Cancer
por: Hille, Claudia, et al.
Publicado: (2019)

Immunohistochemical staining of cytokeratin 20 and cytokeratin 7 in colorectal carcinomas: Four different immunostaining profiles
por: Al-Maghrabi, Jaudah, et al.
Publicado: (2018)

Gene targeting at the mouse cytokeratin 10 locus: severe skin fragility and changes of cytokeratin expression in the epidermis
Publicado: (1996)

Cytokeratin 5 and cytokeratin 6 expressions are unconnected in normal and cancerous tissues and have separate diagnostic implications
por: Völkel, Cosima, et al.
Publicado: (2021)

Expression of cytokeratin-7 and cytokeratin-19 on newborn mice induced rhesus rotavirus as biliary atresia model
por: Setyoboedi, Bagus, et al.
Publicado: (2022)

The Role of Circulating Tumor Cells in the Metastatic Cascade: Biology, Technical Challenges, and Clinical Relevance
por: Dianat-Moghadam, Hassan, et al.
Publicado: (2020)

Release of Full-Length PrP(C) from Cultured Neurons Following Neurotoxic Challenge
por: Wang, Kevin K. W., et al.
Publicado: (2012)

Cytokeratin immunoprofile of primary and metastatic adenoid cystic carcinoma of salivary glands: a report of two cases
por: Nagano, Cibele Pidorodeski, et al.
Publicado: (2016)

Cytokeratin 20-positive hepatocellular carcinoma
por: Fanni, D., et al.
Publicado: (2009)

Cytokeratin 13, Cytokeratin 17, and Ki-67 Expression in Human Acquired Cholesteatoma and Their Correlation With Its Destructive Capacity
por: Hamed, Mahmood A., et al.
Publicado: (2017)

Cytokeratin 5 and cytokeratin 20 inversely correlate with tumour grading in Ta non‐muscle‐invasive bladder cancer
por: Muilwijk, Tim, et al.
Publicado: (2021)

An analysis of Cyclin D1, Cytokeratin 5/6 and Cytokeratin 8/18 expression in breast papillomas and papillary carcinomas
por: Wang, Yu, et al.
Publicado: (2013)

Utility of thyroid transcription factor-1 and cytokeratin 20 in identifying the origin of metastatic carcinomas of cervical lymph nodes.
por: Roh, Mee Sook, et al.
Publicado: (2002)

Presence of Cytokeratin 19-Expressing Cholangiocarcinoma-Like Tumour in a Liver Metastatic Lesion of Rectal Neuroendocrine Tumour
por: Ishii, Norihiro, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7qfpeiuqfs70h0obodr12ejctl